Rob Nicolson

Summary

Country: Canada

Publications

  1. ncbi A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder
    Rob Nicolson
    Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada
    J Am Acad Child Adolesc Psychiatry 44:640-6. 2005
  2. ncbi Detection and mapping of hippocampal abnormalities in autism
    Rob Nicolson
    Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada
    Psychiatry Res 148:11-21. 2006
  3. ncbi Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study
    Timothy J DeVito
    Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada
    Biol Psychiatry 61:465-73. 2007
  4. ncbi A prospective, open-label trial of galantamine in autistic disorder
    Rob Nicolson
    Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
    J Child Adolesc Psychopharmacol 16:621-9. 2006
  5. ncbi Brain magnetic resonance spectroscopy in Tourette's disorder
    Timothy J DeVito
    Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
    J Am Acad Child Adolesc Psychiatry 44:1301-8. 2005
  6. ncbi Childhood onset schizophrenia: familial neurocognitive measures
    Peter A Gochman
    Child Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room 3N202, Bethesda, MD 20892 1600, USA
    Schizophr Res 71:43-7. 2004
  7. ncbi Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members
    Alexandra Sporn
    Child Psychiatry Branch, National Institute of Mental Health, National Institute of Health, Bldg 10, Rm 3N202, Bethesda, MD 20892, USA
    Schizophr Res 73:243-52. 2005
  8. ncbi Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses
    Nitin Gogtay
    Child Psychiatry Branch, National Institute of Mental Health NIH, Building 10, Room 3N202, 10 Center Drive, MSC 1600, Bethesda, MD 20892 1600, USA
    Arch Gen Psychiatry 61:17-22. 2004
  9. ncbi Amoxapine treatment of interfering behaviors in autistic disorder
    Beth Craven-Thuss
    J Am Acad Child Adolesc Psychiatry 42:515-6. 2003
  10. ncbi Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine
    Cara L Alfaro
    National Institutes of Health, Clinical Center Pharmacy Department, Bethesda, Maryland 20892, USA
    J Child Adolesc Psychopharmacol 12:83-91. 2002

Collaborators

  • Arthur W Toga
  • Peter Williamson
  • F Xavier Castellanos
  • Alexandra Sporn
  • Timothy J DeVito
  • Nitin Gogtay
  • Marge Lenane
  • Judith L Rapoport
  • Deanna Greenstein
  • William Pavlosky
  • Richard W J Neufeld
  • Dick J Drost
  • Nagalingam Rajakumar
  • Peter A Gochman
  • Peter Gochman
  • Beth Craven-Thuss
  • Cara L Alfaro
  • Daniel R Weinberger
  • B Duncan McKinlay
  • Michael F Egan
  • Franziska Sailer
  • Daniel W Hommer
  • Robert Rawlings
  • Audrey Keller
  • Alan Evans
  • Liv S Clasen
  • Francis Brookner
  • Jay N Giedd
  • Tom F Nugent
  • Pete Gochman
  • Marianne Wudarsky

Detail Information

Publications10

  1. ncbi A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder
    Rob Nicolson
    Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada
    J Am Acad Child Adolesc Psychiatry 44:640-6. 2005
    ..The purpose of this study was to examine the efficacy and safety of metoclopramide in the treatment of children and adolescents with tic disorders...
  2. ncbi Detection and mapping of hippocampal abnormalities in autism
    Rob Nicolson
    Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada
    Psychiatry Res 148:11-21. 2006
    ..The increased statistical and spatial power of computational mapping methods provided the ability to detect these differences, which were not found with traditional volumetric methods...
  3. ncbi Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study
    Timothy J DeVito
    Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada
    Biol Psychiatry 61:465-73. 2007
    ..The purpose of this study was to examine cerebral gray and white matter cellular neurochemistry in autism with proton magnetic resonance spectroscopic imaging (MRSI)...
  4. ncbi A prospective, open-label trial of galantamine in autistic disorder
    Rob Nicolson
    Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
    J Child Adolesc Psychopharmacol 16:621-9. 2006
    ..The purpose of this study was to assess the use of galantamine, an acetylcholinesterase inhibitor and nicotinic receptor modulator, in the treatment of interfering behaviors in children with autism...
  5. ncbi Brain magnetic resonance spectroscopy in Tourette's disorder
    Timothy J DeVito
    Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
    J Am Acad Child Adolesc Psychiatry 44:1301-8. 2005
    ....
  6. ncbi Childhood onset schizophrenia: familial neurocognitive measures
    Peter A Gochman
    Child Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room 3N202, Bethesda, MD 20892 1600, USA
    Schizophr Res 71:43-7. 2004
    ..Neurocognitive deficits which are seen in families of adult onset schizophrenic patients were examined in healthy family members of patients with childhood-onset schizophrenia (COS)...
  7. ncbi Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members
    Alexandra Sporn
    Child Psychiatry Branch, National Institute of Mental Health, National Institute of Health, Bldg 10, Rm 3N202, Bethesda, MD 20892, USA
    Schizophr Res 73:243-52. 2005
    ..Childhood-onset schizophrenia (COS), a severe form of the disorder, is of interest for etiologic studies. Smooth pursuit eye-tracking dysfunction (ETD) is a biological marker for schizophrenia...
  8. ncbi Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses
    Nitin Gogtay
    Child Psychiatry Branch, National Institute of Mental Health NIH, Building 10, Room 3N202, 10 Center Drive, MSC 1600, Bethesda, MD 20892 1600, USA
    Arch Gen Psychiatry 61:17-22. 2004
    ..We hypothesized that cortical GM loss would occur in patients with COS but not in adolescents with atypical psychoses...
  9. ncbi Amoxapine treatment of interfering behaviors in autistic disorder
    Beth Craven-Thuss
    J Am Acad Child Adolesc Psychiatry 42:515-6. 2003
  10. ncbi Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine
    Cara L Alfaro
    National Institutes of Health, Clinical Center Pharmacy Department, Bethesda, Maryland 20892, USA
    J Child Adolesc Psychopharmacol 12:83-91. 2002
    ..91, p = 0.03); the patient with the highest serum prolactin experienced galactorrhea. Further studies evaluating the prolactin-elevating properties of antipsychotics are warranted in this population...